Prostate Cancer

Choosing hormone therapy for prostate cancer depends on several factors

Published in Cancer Weekly, June 22nd, 2004

Treating advanced prostate cancer with hormonal therapy must consider quality of life issues as well as possible clinical response to treatment.

"Hormonal deprivation has been used for more than 60 years in the treatment of advanced prostate cancer," researchers in France report.

"However, the optimal form of this therapy is still an enigma. This review discusses some of the current challenges in the hormonal management of prostate cancer, regarding complete androgen blockade, intermittent treatment, and the question of whether early hormonal deprivation is superior to delayed therapy," wrote C. Theodore and colleagues, Institute Gustave Roussy,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (2004-06-22)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry